Pittenger & Anderson Inc Novo Nordisk A S Transaction History

Pittenger & Anderson Inc

  • $2.54 Billion
  • Q2 2025

A detailed history of Pittenger & Anderson Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Pittenger & Anderson Inc holds 78,863 shares of NVO stock, worth $4.17 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
78,863
Previous 56,342 39.97%
Holding current value
$4.17 Million
Previous $3.91 Million 39.14%
% of portfolio
0.21%
Previous 0.16%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025
BUY
$58.08 - $81.05 $1.31 Million - $1.83 Million
22,521 Added 39.97%
78,863 $5.44 Million
Q1 2025

May 01, 2025
SELL
$69.3 - $90.95 $284,892 - $373,895
-4,111 Reduced 6.8%
56,342 $3.91 Million
Q4 2024

Jan 31, 2025
BUY
$85.0 - $120.04 $279,735 - $395,051
3,291 Added 5.76%
60,453 $5.2 Million
Q3 2024

Oct 30, 2024
SELL
$119.07 - $145.42 $1.17 Million - $1.43 Million
-9,845 Reduced 14.69%
57,162 $6.81 Million
Q2 2024

Aug 09, 2024
SELL
$122.71 - $146.91 $237,075 - $283,830
-1,932 Reduced 2.8%
67,007 $9.56 Million
Q1 2024

May 02, 2024
SELL
$102.11 - $135.92 $630,631 - $839,441
-6,176 Reduced 8.22%
68,939 $8.85 Million
Q4 2023

Feb 02, 2024
SELL
$87.78 - $105.45 $1.12 Million - $1.34 Million
-12,713 Reduced 14.47%
75,115 $7.77 Million
Q3 2023

Nov 02, 2023
BUY
$90.94 - $199.54 $3.76 Million - $8.25 Million
41,357 Added 89.0%
87,828 $7.99 Million
Q2 2023

Aug 09, 2023
SELL
$155.98 - $172.65 $669,934 - $741,531
-4,295 Reduced 8.46%
46,471 $7.52 Million
Q1 2023

May 10, 2023
SELL
$132.34 - $159.14 $568,003 - $683,028
-4,292 Reduced 7.8%
50,766 $8.08 Million
Q4 2022

Feb 10, 2023
BUY
$102.55 - $135.33 $834,244 - $1.1 Million
8,135 Added 17.34%
55,058 $7.45 Million
Q3 2022

Nov 15, 2022
BUY
$95.28 - $116.93 $186,177 - $228,481
1,954 Added 4.35%
46,923 $4.68 Million
Q2 2022

Jul 14, 2022
BUY
$103.24 - $121.81 $22,093 - $26,067
214 Added 0.48%
44,969 $5.01 Million
Q1 2022

Apr 28, 2022
BUY
$93.1 - $112.54 $931 - $1,125
10 Added 0.02%
44,755 $4.97 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $13,423 - $16,391
-140 Reduced 0.31%
44,745 $5.01 Million
Q3 2020

Nov 10, 2020
BUY
$63.69 - $70.22 $8,916 - $9,830
140 Added 0.31%
44,885 $3.12 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $20,489 - $23,779
-350 Reduced 0.78%
44,745 $2.93 Million
Q1 2020

Apr 30, 2020
BUY
$49.46 - $64.78 $74,190 - $97,170
1,500 Added 3.44%
45,095 $2.72 Million
Q3 2019

Nov 14, 2019
BUY
$47.54 - $53.43 $28,286 - $31,790
595 Added 1.38%
43,595 $2.25 Million
Q1 2019

May 10, 2019
BUY
$46.36 - $52.63 $115,900 - $131,575
2,500 Added 6.17%
43,000 $2.25 Million
Q4 2018

Feb 14, 2019
BUY
$41.54 - $47.25 $1.68 Million - $1.91 Million
40,500 New
40,500 $1.87 Million

Others Institutions Holding NVO

# of Institutions
1,705
Shares Held
311M
Call Options Held
13.7M
Put Options Held
19.7M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $119B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pittenger & Anderson Inc Portfolio

Follow Pittenger & Anderson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email